Profile of viral load, integration, and E2 gene disruption of HPV58 in normal cervix and cervical neoplasia.
暂无分享,去创建一个
Tak-Hong Cheung | So Fan Yim | Julian W. Tang | J. Tang | P. Chan | T. Cheung | S. Yim | Keith W.K. Lo | S. Siu | Paul K.S. Chan | J. L. Cheung | Jo L.K. Cheung | Shing-Shun N. Siu | K. Lo
[1] Yongge Wu,et al. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China. , 2007, Gynecologic oncology.
[2] J. Tang,et al. Viral load, E2 gene disruption status, and lineage of human papillomavirus type 16 infection in cervical neoplasia. , 2006, The Journal of infectious diseases.
[3] C. Cuvelier,et al. Prevalence of high risk human papillomavirus types among Nicaraguan women with histological proved pre-neoplastic and neoplastic lesions of the cervix , 2006, Sexually Transmitted Infections.
[4] Shih-hung Huang,et al. Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer. , 2006, Gynecologic oncology.
[5] S. Franceschi,et al. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study , 2006, British Journal of Cancer.
[6] C. Peyton,et al. Human Papillomavirus Type 16 Integration in Cervical Carcinoma In Situ and in Invasive Cervical Cancer , 2006, Journal of Clinical Microbiology.
[7] J. Doorbar,et al. Molecular biology of human papillomavirus infection and cervical cancer. , 2006, Clinical science.
[8] C. Chou,et al. The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: a Taiwan Cooperative Oncologic Group Study , 2006, International Journal of Gynecologic Cancer.
[9] S. Nieh,et al. Differential viral loads of human papillomavirus 16 and 58 infections in the spectrum of cervical carcinogenesis , 2005, International Journal of Gynecologic Cancer.
[10] P. Chan,et al. Biases in human papillomavirus genotype prevalence assessment associatedwith commonly used consensus primers , 2006, International journal of cancer.
[11] U. Gyllensten,et al. Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN) , 2005, British Journal of Cancer.
[12] N. Nagelkerke,et al. Can viral load, semi-quantitatively evaluated, of human papillomavirus predict cytological or histological outcome in women with atypical squamous or glandular cells of undetermined significance cytology? , 2005, European journal of gynaecological oncology.
[13] A. Biri,et al. Assessment of human papilloma viral load of archival cervical intraepithelial neoplasia by real-time polymerase chain reaction in a Turkish population. , 2005, European journal of gynaecological oncology.
[14] M. Grace,et al. Mechanisms of Human Papillomavirus-Induced Oncogenesis , 2004, Journal of Virology.
[15] E. Kubista,et al. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. , 2004, Gynecologic oncology.
[16] M. Puerto-Solís,et al. High prevalence of human papillomavirus type 58 in Mexican colposcopy patients. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[17] C. R. Martins,et al. Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil. , 2003, Memorias do Instituto Oswaldo Cruz.
[18] F. X. Bosch,et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.
[19] M. Plummer,et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis , 2003, British Journal of Cancer.
[20] P. Chan,et al. Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. , 2002, The Journal of infectious diseases.
[21] P. Chan,et al. Association of human papillomavirus type 58 variant with the risk of cervical cancer. , 2002, Journal of the National Cancer Institute.
[22] A. Venuti,et al. HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness , 2002, Journal of medical virology.
[23] A. Teyssié,et al. Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[24] P. Chan,et al. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions , 1999, Journal of medical virology.
[25] J. Peto,et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.
[26] W. Reeves,et al. Human Papillomavirus (HPV) DNA Copy Number Is Dependent on Grade of Cervical Disease and HPV Type , 1999, Journal of Clinical Microbiology.
[27] R. Holm,et al. Disruption of the E1 and E2 Reading Frames of HPV 16 in Cervical Carcinoma Is Associated with Poor Prognosis , 1998, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[28] V. Giaché,et al. Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. , 1997, Journal of clinical pathology.
[29] Chien-Jen Chen,et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women , 1997, International journal of cancer.
[30] P. Lambert,et al. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells , 1995, Journal of virology.
[31] P. Lambert,et al. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Cuzick,et al. Semi‐quantitative human papillomavirus DNA detection in the management of women with minor cytological abnormality , 1994, British journal of obstetrics and gynaecology.
[33] J. Cuzick,et al. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. , 1994, British Journal of Cancer.